A detailed history of Optiver Holding B.V. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 323 shares of MXCT stock, worth $1,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
323
Previous 787 58.96%
Holding current value
$1,327
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.68 - $5.06 $1,707 - $2,347
-464 Reduced 58.96%
323 $1,000
Q2 2024

Aug 14, 2024

BUY
$3.63 - $5.0 $765 - $1,055
211 Added 36.63%
787 $3,000
Q1 2024

May 09, 2024

BUY
$3.94 - $5.38 $2,269 - $3,098
576 New
576 $2,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $418M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.